Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hoffman

Showing results (751-760 of 812) with videos related to

Pageof 82
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
AIDS and Behavior|November 28, 2025
Poor Oral HIV Pre-Exposure Prophylaxis (PrEP) Persistence in an Integrated PrEP/STI Program in MalawiGrace E Mulholland, Mitch Matoga, Jane S Chen, et al.
Molecular Pharmacology|November 2, 2012
BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosisXiaoyan Tang, Ruoqi Peng, Yonglin Ren, et al.
The Journal of Infectious Diseases|December 31, 2011
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo testNora E Rosenberg, Gift Kamanga, Sam Phiri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2015
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, MalawiSarah E Rutstein, Audrey E Pettifor, Sam Phiri, et al.
BMC Health Services Research|July 3, 2025
Assisted partner notification as a strategy to enhance Pre-Exposure Prophylaxis (PrEP) screening and uptake - results from a prospective cohort study in Lilongwe, MalawiTapiwa Munthali, Angella Masano, Jane S Chen, et al.
Journal of Virology|July 10, 1999
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variantsL H Ping, J A Nelson, I F Hoffman, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|March 28, 2019
Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074Kathryn E Lancaster, William C Miller, Tetiana Kiriazova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2018
Human Immunodeficiency Virus (HIV)-1 Transmission Among Persons With Acute HIV-1 Infection in Malawi: Demographic, Behavioral, and Phylogenetic RelationshipsAnn M Dennis, Myron S Cohen, Katherine B Rucinski, et al.
AIDS (London, England)|February 19, 2011
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenSalim S Abdool Karim, Barbra A Richardson, Gita Ramjee, et al.
Pageof 82

Showing results (751-760 of 812) with videos related to

Sort By:
Pageof 82
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinaseMark T Bilodeau, Leonard D Rodman, Georgia B McGaughey, et al.
AIDS and Behavior|November 28, 2025
Poor Oral HIV Pre-Exposure Prophylaxis (PrEP) Persistence in an Integrated PrEP/STI Program in MalawiGrace E Mulholland, Mitch Matoga, Jane S Chen, et al.
Molecular Pharmacology|November 2, 2012
BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosisXiaoyan Tang, Ruoqi Peng, Yonglin Ren, et al.
The Journal of Infectious Diseases|December 31, 2011
Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo testNora E Rosenberg, Gift Kamanga, Sam Phiri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2015
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, MalawiSarah E Rutstein, Audrey E Pettifor, Sam Phiri, et al.
BMC Health Services Research|July 3, 2025
Assisted partner notification as a strategy to enhance Pre-Exposure Prophylaxis (PrEP) screening and uptake - results from a prospective cohort study in Lilongwe, MalawiTapiwa Munthali, Angella Masano, Jane S Chen, et al.
Journal of Virology|July 10, 1999
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variantsL H Ping, J A Nelson, I F Hoffman, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|March 28, 2019
Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074Kathryn E Lancaster, William C Miller, Tetiana Kiriazova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2018
Human Immunodeficiency Virus (HIV)-1 Transmission Among Persons With Acute HIV-1 Infection in Malawi: Demographic, Behavioral, and Phylogenetic RelationshipsAnn M Dennis, Myron S Cohen, Katherine B Rucinski, et al.
AIDS (London, England)|February 19, 2011
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenSalim S Abdool Karim, Barbra A Richardson, Gita Ramjee, et al.
Pageof 82